- Home
- Publications
- Publication Search
- Publication Details
Title
Update on obesity pharmacotherapy
Authors
Keywords
-
Journal
Annals of the New York Academy of Sciences
Volume 1311, Issue 1, Pages 1-13
Publisher
Wiley
Online
2014-03-19
DOI
10.1111/nyas.12328
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effectiveness of Primary Care–Relevant Treatments for Obesity in Adults: A Systematic Evidence Review for the U.S. Preventive Services Task Force
- (2013) Erin S. LeBlanc et al. ANNALS OF INTERNAL MEDICINE
- Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial
- (2013) William T Cefalu et al. LANCET
- Obesity in young men, and individual and combined risks of type 2 diabetes, cardiovascular morbidity and death before 55 years of age: a Danish 33-year follow-up study
- (2013) Morten Schmidt et al. BMJ Open
- Medical Therapy for the Patient With Obesity
- (2012) George A. Bray et al. CIRCULATION
- Long-Term Safety, Tolerability, and Weight Loss Associated With Metformin in the Diabetes Prevention Program Outcomes Study
- (2012) DIABETES CARE
- Association of an Intensive Lifestyle Intervention With Remission of Type 2 Diabetes
- (2012) Edward W. Gregg et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The FDA's Assessment of Two Drugs for Chronic Weight Management
- (2012) Eric Colman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Placebo-Controlled Clinical Trial of Lorcaserin for Weight Loss in Type 2 Diabetes Mellitus: The BLOOM-DM Study
- (2012) Patrick M. O'Neil et al. Obesity
- Systematic review of SGLT2 receptor inhibitors in dual or triple therapy in type 2 diabetes
- (2012) Christine Clar et al. BMJ Open
- Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study
- (2011) W Timothy Garvey et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- An overview of once-weekly glucagon-like peptide-1 receptor agonists-available efficacy and safety data and perspectives for the future
- (2011) S. Madsbad et al. DIABETES OBESITY & METABOLISM
- A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial
- (2011) Meredith C. Fidler et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial
- (2011) Kishore M Gadde et al. LANCET
- Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP)
- (2011) David B. Allison et al. Obesity
- Effects of Exenatide Combined with Lifestyle Modification in Patients with Type 2 Diabetes
- (2010) Caroline M. Apovian et al. AMERICAN JOURNAL OF MEDICINE
- Randomized controlled trial to investigate the effects of a newly developed formulation of phentermine diffuse-controlled release for obesity
- (2010) J. G. Kang et al. DIABETES OBESITY & METABOLISM
- Prevalence and Trends in Obesity Among US Adults, 1999-2008
- (2010) Katherine M. Flegal JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prevalence of High Body Mass Index in US Children and Adolescents, 2007-2008
- (2010) Cynthia L. Ogden JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Lorcaserin, A 5-HT2CReceptor Agonist, Reduces Body Weight by Decreasing Energy Intake without Influencing Energy Expenditure
- (2010) Corby K. Martin et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
- (2010) Frank L Greenway et al. LANCET
- Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management
- (2010) Steven R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enhanced Weight Loss Following Coadministration of Pramlintide With Sibutramine or Phentermine in a Multicenter Trial
- (2010) Louis J. Aronne et al. Obesity
- Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR-BMOD Trial
- (2010) Thomas A. Wadden et al. Obesity
- Metformin and Insulin Suppress Hepatic Gluconeogenesis through Phosphorylation of CREB Binding Protein
- (2009) Ling He et al. CELL
- Serotonergic drugs and valvular heart disease
- (2009) Richard B Rothman et al. Expert Opinion On Drug Safety
- Changes in weight and metabolic parameters during treatment with antipsychotics and metformin: do the data inform as to potential guideline development? A systematic review of clinical studies
- (2009) C. J. Bushe et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Pharmacokinetics, Safety, and Tolerability of Phentermine in Healthy Participants Receiving Taranabant, a Novel Cannabinoid-1 Receptor (CB1R) Inverse Agonist
- (2009) Carol Addy et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
- (2009) Arne Astrup et al. LANCET
- 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study
- (2009) LANCET
- How Physician Obesity Specialists Use Drugs to Treat Obesity
- (2009) Ed J. Hendricks et al. Obesity
- Rational Design of a Combination Medication for the Treatment of Obesity
- (2008) Frank L. Greenway et al. Obesity
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now